Back
KalVista Pharmaceuticals, Inc. Stock Predictions
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets
Buy
66
KALV
KalVista Pharmaceuticals, Inc.
Last Price:
$16.02
Seasonality Move:
3.72%
7 Day Trial
ALL ACCESS PASS
$
7
99.6% Win Rate Across 508 Picks (Third-Party Audited)
See how Decentralized Masters' system identifies 10x-100x opportunities before Coinbase. Watch free training.KalVista Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, KalVista Pharmaceuticals, Inc. has on average historically risen by 9.1% based on the past 10 years of stock performance.
-
KalVista Pharmaceuticals, Inc. has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is KalVista Pharmaceuticals, Inc. Stock Undervalued?The current KalVista Pharmaceuticals, Inc. [KALV] share price is $16.54. The Score for KALV is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
KALV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will KalVista Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, KalVista Pharmaceuticals, Inc. has on average historically risen by 9.1% based on the past 10 years of stock performance.
KalVista Pharmaceuticals, Inc. Stock Rating
Buy
66
KalVista Pharmaceuticals, Inc. (KALV)
is a Buy
Is KalVista Pharmaceuticals, Inc. overpriced?
-
KalVista Pharmaceuticals, Inc. has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
KalVista Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kalvista.com
52-Week Data
52-Week High:
19.00
52-Week Low:
8.40
Prediction Charts
Market Cap:
822.4M
Price in USD:
16.54
Volume:
689.3K
Beta:
1.10
Technical Analysis
SMA50:
14.95
SMA100:
13.70
SMA200:
13.30
52-Wk Change:
93.22%
Stock Predictions
-
Is KalVista Pharmaceuticals, Inc. stock public?Yes, KalVista Pharmaceuticals, Inc. is a publicly traded company.
-
What is the KalVista Pharmaceuticals, Inc. stock quote today?The KalVista Pharmaceuticals, Inc. stock price is 16.54 USD today.
-
How to buy KalVista Pharmaceuticals, Inc. stock online?You can buy KalVista Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-31 | 15.61 | 16.15 | 16.45 | 15.33 |
| Jan-5 | 15.38 | 15.66 | 15.70 | 15.12 |
| Jan-6 | 15.96 | 15.75 | 16.17 | 15.19 |
| Jan-7 | 16.00 | 16.34 | 16.79 | 15.80 |
| Jan-8 | 16.40 | 15.82 | 16.44 | 15.77 |
| Jan-9 | 18.60 | 16.80 | 19.00 | 16.01 |
| Jan-12 | 16.77 | 16.39 | 16.77 | 15.39 |
| Jan-13 | 16.40 | 14.94 | 16.40 | 14.80 |
| Jan-14 | 14.93 | 15.24 | 15.66 | 14.79 |
| Jan-15 | 15.26 | 14.96 | 15.46 | 14.70 |
| Jan-16 | 14.93 | 14.60 | 15.14 | 14.45 |
| Jan-20 | 14.25 | 15.31 | 15.75 | 14.22 |
| Jan-21 | 15.25 | 15.91 | 15.93 | 15.16 |
| Jan-22 | 15.95 | 16.54 | 16.65 | 15.84 |
KalVista Pharmaceuticals, Inc. Earnings
KalVista Pharmaceuticals, Inc. Earnings Report: Per Share KalVista Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
KalVista Pharmaceuticals, Inc. Forecast Revenue Growth
KalVista Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for KalVista Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.90 per share, and an increase next year of $2.49 per share.
* KalVista Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.